Proof of concept, randomized, placebo-controlled study of the effect of simvastatin on the course of age-related macular degeneration.
<h4>Background</h4>HMG Co-A reductase inhibitors are ubiquitous in our community yet their potential role in age-related macular degeneration (AMD) remains to be determined.<h4>Methodology/principal findings</h4><h4>Objectives</h4>To evaluate the effect of simvast...
Guardado en:
Autores principales: | Robyn H Guymer, Paul N Baird, Mary Varsamidis, Lucy Busija, Peter N Dimitrov, Khin Zaw Aung, Galina A Makeyeva, Andrea J Richardson, Lyndell Lim, Liubov D Robman |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/af9016b6ce98442ab17214514f70a60a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Can HMG Co-A reductase inhibitors (“statins”) slow the progression of age-related macular degeneration? The Age-Related Maculopathy Statin Study (ARMSS)
por: Robyn H Guymer, et al.
Publicado: (2008) -
Comprehensive analysis of Copy Number Variation of genes at chromosome 1 and 10 loci associated with late age related macular degeneration.
por: Stuart Cantsilieris, et al.
Publicado: (2012) -
Adjunctive simvastatin treatment in schizophrenia patients; a double blind randomized and placebo controlled trial
por: Somaieh Ashrafi, et al.
Publicado: (2022) -
The role of the ERK1/2 pathway in simvastatin-loaded nanomicelles and simvastatin in regulating the osteogenic effect in MG63 cells
por: Niu M, et al.
Publicado: (2018) - Proof